Literature DB >> 2474354

The action of dopamine and vascular dopamine (DA1) receptor agonists on human isolated subcutaneous and omental small arteries.

A D Hughes1, P S Sever.   

Abstract

1. Human small arteries were obtained from surgical specimens and studied in vitro by use of a myograph technique. Following induction of tone with a potassium depolarizing solution, dopamine in the presence of beta-adrenoceptor and catecholamine uptake blockade relaxed isolated omental and subcutaneous arteries. Preincubation of tissues with phentolamine increased the maximum relaxation in response to dopamine. 2. The selective vascular dopamine receptor agonists, fenoldopam and SKF 38393 also relaxed isolated subcutaneous and omental arteries in a concentration-dependent manner. The order of potency for agonists was dopamine greater than fenoldopam greater than SKF 38393. 3. Dopamine-induced relaxation was competitively antagonized by SCH 23390, (R)- and (S)-sulpiride, and fenoldopam induced relaxation by SCH 23390 and (+)- but not (-)-butaclamol. 4. These results indicate the presence of vascular dopamine receptors (DA1 subtype) on human isolated resistance arteries from omental and subcutaneous sites.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2474354      PMCID: PMC1854589          DOI: 10.1111/j.1476-5381.1989.tb12036.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  34 in total

1.  Vascular effects of selective dopamine receptor agonists and antagonists in the rat kidney.

Authors:  M Schmidt; J P Krieger; E M Giesen-Crouse; J L Imbs
Journal:  Arch Int Pharmacodyn Ther       Date:  1987-04

2.  Subclassification of peripheral dopamine receptors.

Authors:  A Hilditch; G M Drew
Journal:  Clin Exp Hypertens A       Date:  1987

Review 3.  Cardiovascular and renal actions of dopamine: potential clinical applications.

Authors:  L I Goldberg
Journal:  Pharmacol Rev       Date:  1972-03       Impact factor: 25.468

Review 4.  The fourth Sir George Pickering memorial lecture. The structure of the resistance vasculature in essential hypertension.

Authors:  M J Mulvany
Journal:  J Hypertens       Date:  1987-04       Impact factor: 4.844

5.  A method for presenting and comparing dose-response curves.

Authors:  J R Carpenter
Journal:  J Pharmacol Methods       Date:  1986-07

6.  Dopamine-containing vasomotor nerves in the dog kidney.

Authors:  C Bell; W J Lang; F Laska
Journal:  J Neurochem       Date:  1978-07       Impact factor: 5.372

7.  Inhibition of dopamine-stimulated adenylate cyclase activity by phenoxybenzamine.

Authors:  K G Walton; P Liepmann; R J Baldessarini
Journal:  Eur J Pharmacol       Date:  1978-11-15       Impact factor: 4.432

8.  Dopamine produces forearm vasodilatation following alpha-adrenoceptor blockade by an action on vascular dopamine (DA1) receptors in man.

Authors:  A D Hughes; S A Thom; N M Woodall; D Redman; P S Sever
Journal:  J Hypertens       Date:  1987-06       Impact factor: 4.844

9.  Comparison of the effects of fenoldopam, SK & F R-87516 and dopamine on renal arterioles in vitro.

Authors:  R M Edwards
Journal:  Eur J Pharmacol       Date:  1986-07-15       Impact factor: 4.432

10.  Evidence for different states of the dopamine D1 receptor: clozapine and fluperlapine may preferentially label an adenylate cyclase-coupled state of the D1 receptor.

Authors:  P H Andersen; C Braestrup
Journal:  J Neurochem       Date:  1986-12       Impact factor: 5.372

View more
  1 in total

1.  Exposure and characterization of the action of noradrenaline at dopamine receptors mediating endothelium-independent relaxation of rat isolated small mesenteric arteries.

Authors:  P H Van der Graaf; P R Saxena; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.